Fortress Biotech (FBIO)
(Real Time Quote from BATS)
$1.75 USD
+0.02 (1.16%)
Updated Aug 8, 2024 11:46 AM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
Fortress Biotech, Inc. [FBIO]
Reports for Purchase
Showing records 301 - 317 ( 317 total )
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
Corrected - Coverage Update - Healthcare
Provider: Roth Capital Partners, Inc.
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
We are transferring coverage of FBIO to Sa''ar Yaniv, due to the departure of the covering analyst and placing shares Under Review
Provider: Roth Capital Partners, Inc.
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
ROTH Healthcare Monthly - Longing for Better Blood at ASH
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
Nice Early Look at Mustang''s MB-101; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Innovations in Oncology Corporate Access Day Recap
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
3Q16 Results; Driving Current Assets and Search for New Ones Continues
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
A New Addition to the Family; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
Helocyte''s Triplex Pointing in the Right Direction; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
Journey''s Product Portfolio Grows; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare: Inaugural Healthcare Monthly; Catalysts Galore
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
It''s All About the Big Picture; Assets and Ownership; Initiating at Buy
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Fortress Biotech, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.